Technical Analysis for PHAS - PhaseBio Pharmaceuticals, Inc.
|Grade||Last Price||% Change||Price Change|
PHAS closed down 7.36 percent on Thursday, December 13, 2018, on 40 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
|See historical PHAS trend table...|
|Date||Alert Name||Type||% Chg|
|Dec 13||New Downtrend||Bearish||0.00%|
|Dec 13||Wide Bands||Range Expansion||0.00%|
|Dec 13||Overbought Stochastic||Strength||0.00%|
|Dec 12||Narrow Range Bar||Range Contraction||-7.36%|
|Dec 12||NR7||Range Contraction||-7.36%|
|Dec 12||NR7-2||Range Contraction||-7.36%|
|Dec 12||Wide Bands||Range Expansion||-7.36%|
|Dec 12||Overbought Stochastic||Strength||-7.36%|
|Dec 11||180 Bullish Setup||Bullish Swing Setup||-5.44%|
|Dec 11||Narrow Range Bar||Range Contraction||-5.44%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat orphan diseases with an initial focus on cardiopulmonary indications. Its lead product candidate, PB2452, is a reversal agent for the antiplatelet drug ticagrelor that has completed a Phase 1 clinical trial and is been developed for the treatment of patients on ticagrelor who are experiencing a major bleeding event or those who require urgent surgery. It is also developing PB1046, a fusion protein currently in a Phase 2b clinical trial for the treatment of pulmonary arterial hypertension. The company was founded in 2002 and is based in Malvern, Pennsylvania.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more PHAS news...
|52 Week High||6.0|
|52 Week Low||2.55|
|200-Day Moving Average||0.0|
|50-Day Moving Average||0.0|
|20-Day Moving Average||3.2765|
|10-Day Moving Average||3.517|
|Average True Range||0.3687|
|Chandelier Exit (Long, 3 ATRs )||4.0839|
|Chandelier Exit (Short, 3 ATRs )||3.6561|
|Upper Bollinger Band||4.1615|
|Lower Bollinger Band||2.3915|
|Percent B (%b)||0.71|
|MACD Signal Line||-0.4218|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||4.30|
|Resistance 3 (R3)||4.32||4.13||4.19|
|Resistance 2 (R2)||4.13||3.97||4.12||4.15|
|Resistance 1 (R1)||3.89||3.86||3.80||3.87||4.12|
|Support 1 (S1)||3.46||3.54||3.37||3.44||3.18|
|Support 2 (S2)||3.27||3.43||3.26||3.15|
|Support 3 (S3)||3.03||3.27||3.11|
|Support 4 (S4)||3.01|